ArticlePloS one2026
Optimal exercise modalities and dosages for improving depression in middle-aged and older adults with Parkinson's disease: A Bayesian Dose-response network meta-analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo characterise the dose response relationship between exercise and depressive symptoms in middle aged and older adults with Parkinson disease using a continuous modelling framework and to compare structural differences across exercise modalities.
methodsPubMed, Embase, Web of Science, Cochrane Library and APA PsycINFO were searched to 19 February 2026. Exercise dose was standardised as MET-minutes per week. A Bayesian network meta-regression model was used to estimate continuous dose-response relationships. Evidence certainty was assessed using GRADE.
resultsTwenty-five RCTs were included. Overall exercise dose showed a significant non-linear association with reduced depressive symptoms in middle-aged and older adults with Parkinson disease. Beneficial effects were sustained between 110 and 890 MET-minutes per week, peaking at 560 MET-minutes per week (effect size 0.48, 95% credible interval 0.22-0.80), with an optimal range of 440-670 MET-minutes per week. Effects were not stable at 1000 MET-minutes per week. Modality analyses indicated that exercise combined with cognitive training and mind-body exercise demonstrated consistent benefits within moderate to moderately high dose ranges, both peaking at 560 MET-minutes per week. Aerobic cycling, functional training, and multicomponent training showed no stable significant dose range, whereas walking reached significance only at ≥670 MET-minutes per week with wide credible intervals.
conclusionExercise in middle-aged and older adults with Parkinson disease and comorbid depression exhibits a structured non-linear dose-response pattern with a defined optimal range, and modality-specific differences indicate that therapeutic effects depend on both quantitative dose and qualitative task characteristics, providing a quantitative basis for precision exercise prescription.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.